Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Pfizer Inc

(NYSE: PFE)
Add to Portfolio
+0.01 (+0.03%)
as of 13:45 EST

Sangamo and Pfizer Announce Updated Phase 1/2 Results

BusinessWire via COMTEX - Sat Dec 07, 09:00AM EST
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, and Pfizer, Inc. (NYSE: PFE), today announced updated follow-up results from the Phase 1/2 Alta study evaluating investigational SB-525 gene therapy in patient(full story)
SGMO: 10.96 (-0.70), PFE: 38.30 (+0.01)

After Yesterday's Decline of 1.10%, Pfizer Inc Offers

Comtex SmarTrend(R) via COMTEX - Tue Dec 03, 12:57PM EST
Pfizer Inc (NYSE:PFE) traded in a range yesterday that spanned from a low of $37.84 to a high of $38.05. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $38.25 on volume of 693,000 shares. O(full story)
PFE: 38.30 (+0.01)

Pfizer Inc Falls 1.10% on Heavy Volume: Watch For

Comtex SmarTrend(R) via COMTEX - Tue Dec 03, 12:57PM EST
Pfizer Inc (NYSE:PFE) traded in a range yesterday that spanned from a low of $37.84 to a high of $38.05. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $38.25 on volume of 693,000 shares. O(full story)
PFE: 38.30 (+0.01)

NavaDerm Partners adds Dan Wechsler as Executive

PR Newswire via COMTEX - Mon Dec 02, 11:15AM EST
NavaDerm Partners ("NavaDerm" or the "Company"), a Northeast-focused dermatology services company and portfolio company of BelHealth Investment Partners ("BelHealth"), a New York-based healthcare private equity firm, announced the(full story)
MLNT: 1.67 (-0.07), MRK: 88.78 (-0.07), PFE: 38.30 (+0.01)

Pfizer Invites Public to Listen to Webcast of Pfizer

BusinessWire via COMTEX - Wed Nov 27, 10:00AM EST
Pfizer Inc. invites investors and the general public to listen to a webcast of a discussion with Mikael Dolsten, Chief Scientific Officer and President, Worldwide Research, Development and Medical, and Michael Vincent, Senior Vice(full story)
PFE: 38.30 (+0.01)